State of Wyoming Invests $697,000 in Envista Holdings Corporation $NVST

State of Wyoming purchased a new position in Envista Holdings Corporation (NYSE:NVST) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 26,457 shares of the company’s stock, valued at approximately $697,000.

Several other hedge funds have also recently bought and sold shares of the company. Parallel Advisors LLC boosted its position in Envista by 13.1% during the fourth quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after purchasing an additional 367 shares in the last quarter. Bank of Montreal Can increased its position in shares of Envista by 1.4% in the fourth quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock valued at $568,000 after buying an additional 372 shares in the last quarter. Sepio Capital LP increased its position in shares of Envista by 1.2% in the fourth quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock valued at $687,000 after buying an additional 374 shares in the last quarter. Deutsche Bank AG raised its stake in shares of Envista by 2.9% during the 4th quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after buying an additional 484 shares during the last quarter. Finally, State of Michigan Retirement System raised its stake in shares of Envista by 1.5% during the 1st quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock worth $1,001,000 after buying an additional 600 shares during the last quarter.

Analyst Ratings Changes

A number of brokerages recently commented on NVST. Barclays lowered their price objective on shares of Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, June 11th. Wall Street Zen downgraded shares of Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 9th. Evercore reiterated an “outperform” rating and issued a $33.00 price target on shares of Envista in a research report on Thursday, May 7th. Weiss Ratings raised shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 6th. Finally, Robert W. Baird set a $34.00 price objective on Envista in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, Envista has a consensus rating of “Moderate Buy” and a consensus target price of $29.31.

Envista Trading Down 0.1%

Shares of NVST stock opened at $28.05 on Monday. The firm has a 50-day moving average price of $26.57 and a 200 day moving average price of $26.17. Envista Holdings Corporation has a twelve month low of $18.77 and a twelve month high of $30.42. The company has a market capitalization of $4.50 billion, a price-to-earnings ratio of 48.35, a PEG ratio of 1.34 and a beta of 0.86. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last released its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. During the same period in the prior year, the firm earned $0.26 EPS. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Research analysts forecast that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.